Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03377361
Title	An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread (CheckMate 9N9)
Acronym	CheckMate 9N9
Recruitment	Active, not recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Bristol-Myers Squibb
Indications	colorectal adenocarcinoma
Therapies	Regorafenib Ipilimumab + Nivolumab + Trametinib Nivolumab + Trametinib
Age Groups:	adult \| senior
Covered Countries	USA \| ITA \| ESP \| DEU \| CZE \| CAN \| BEL \| AUS \| ARG